| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 1352 | 2023 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 573 | 2022 |
| Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020 D Bryazka, MB Reitsma, MG Griswold, KH Abate, C Abbafati, ... The Lancet 400 (10347), 185-235, 2022 | 327 | 2022 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 232 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 231 | 2024 |
| Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019 S Momtazmanesh, SS Moghaddam, SH Ghamari, EM Rad, N Rezaei, ... EClinicalMedicine 59, 2023 | 224 | 2023 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 219 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 182 | 2024 |
| Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 WM Gardner, C Razo, TA McHugh, H Hagins, VM Vilchis-Tella, ... The Lancet Haematology 10 (9), e713-e734, 2023 | 161 | 2023 |
| Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global … YH Shin, J Hwang, R Kwon, SW Lee, MS Kim, ... Allergy 78 (8), 2232-2254, 2023 | 116 | 2023 |
| Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019 AE Peden, P Cullen, KL Francis, H Moeller, MM Peden, P Ye, M Tian, ... The Lancet public health 7 (8), e657-e669, 2022 | 48 | 2022 |
| Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 D Wu, Y Jin, Y Xing, MD Abate, M Abbasian, M Abbasi-Kangevari, ... EClinicalMedicine 64, 2023 | 37 | 2023 |
| Contribution of miRNAs and lncRNAs in osteogenesis and related disorders S Ghafouri-Fard, A Abak, ST Avval, S Rahmani, H Shoorei, M Taheri, ... Biomedicine & pharmacotherapy 142, 111942, 2021 | 33 | 2021 |
| Effect of air pollution on disease burden, mortality, and life expectancy in North Africa and the Middle East: a systematic analysis for the global burden of disease study 2019 M Abbasi-Kangevari, MR Malekpour, M Masinaei, SS Moghaddam, ... The Lancet Planetary Health 7 (5), e358-e369, 2023 | 31 | 2023 |
| The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease … S Samadzadeh Lancet 402 (10398), 313-335, 2023 | 27 | 2023 |
| Omicron (B. 1.1. 529) variant: Development, dissemination, and dominance S Rahmani, N Rezaei Journal of medical virology 94 (5), 1787, 2022 | 26 | 2022 |
| Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: A systematic review F Nabizadeh, M Noori, S Rahmani, H Hosseini Journal of Clinical Neuroscience 111, 57-70, 2023 | 25 | 2023 |
| Synaptic plasticity and depression: the role of miRNAs dysregulation S Rahmani, S Kadkhoda, S Ghafouri-Fard Molecular Biology Reports 49 (10), 9759-9765, 2022 | 21 | 2022 |
| Depresssion, anxiety and other cognitive consequences of social isolation: drug and non‐drug treatments Z Taheri Zadeh, S Rahmani, F Alidadi, S Joushi, K Esmaeilpour International journal of clinical practice 75 (12), e14949, 2021 | 20 | 2021 |
| Efficacy of tocilizumab in the treatment of COVID‐19: An umbrella review MM Rezaei Tolzali, M Noori, P Shokri, S Rahmani, S Khanzadeh, ... Reviews in Medical Virology 32 (6), e2388, 2022 | 16 | 2022 |
